Mr. Pasternak brings decades of global pharmaceutical leadership experience Transition further highlights transformation of ...
Hosted on MSN3d
'I know how defeats are taken around home' - Errigal Ciaran is a family affair for McGinleysUse precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced the appointment of Andy Pasternak as Chairman of ...
We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...
We recently compiled a list of the 13 Highest Yielding Dividend Stocks in the Dow. In this article, we are going to take a ...
In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best NASDAQ dividend stocks to buy. The NASDAQ, heavily comprised of technology stocks ...
Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $310.00. The ...
Amgen Inc. closed $79.75 short of its 52-week high ($346.85), which the company achieved on July 25th.
Jefferies analyst Michael Yee maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $350.00. The company’s shares closed yesterday at $267.10. Discover ...
His career has included stops at Eli Lilly, Novian Health and, for the last 16 years, Amgen. His tenure at Amgen included roles in sales and marketing for many of its hematology and oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback